# WeightRx reviews (2026): GLP-1 telehealth sellers | This GLP

Tirzepatide costs $83 and semaglutide costs $250, which reverses the usual order.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/weightrx
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Tirzepatide is the cheap one

# WeightRx review

Tirzepatide costs $83 and semaglutide costs $250, which reverses the usual order.

## The verdict

WeightRx publishes $83 a month for compounded tirzepatide and $250 for semaglutide. Both figures appear on the homepage. The tirzepatide line is the cheaper of the two.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

From

From $83/mo

Prescription

Required

Compounded

Yes — not FDA-approved

WeightRx sells both molecules by injection. Two figures are published together. The dual agonist is priced below the single one.

1.  ## Who writes the prescription, and what do they see?
    
    A prescription precedes shipping. The homepage carries the prices. No clinician is described.
    
    Tirzepatide normally carries a premium of fifty to a hundred dollars. Here it is a third of the semaglutide figure, and nothing on the pages explains the inversion.
    
2.  ## What happens when the dose goes up?
    
    Nothing is published about dose on either line. With the molecule pricing already inverted, a reader has no way to check whether the pattern holds as the dose rises.
    
3.  ## What the price includes
    
    Six months of tirzepatide at $83 is $498 and semaglutide at $250 is $1,500. A three-fold gap in the unusual direction is worth confirming with the seller before ordering, because a transposition would explain it too.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
    

## Where it holds up, and where it does not

-   Strength: Both figures published on one page
-   Strength: Tirzepatide is unusually cheap here
-   Strength: Both molecules are offered
-   Limitation: The molecule pricing is inverted
-   Limitation: Nothing explains the inversion
-   Limitation: No milligram dose published
-   Limitation: No state coverage list is recorded

## What the evidence says about this kind of treatment

The assessment above is about WeightRx. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader wanting tirzepatide who will confirm the figure before ordering.

Wrong for

A reader shopping the semaglutide line on price.

## The evidence behind what WeightRx prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How WeightRx compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| VyrarX | Readers who will ask what maintenance costs before starting |  |
| YourHealthRx | Readers in any jurisdiction wanting a flat rate with little to decide |  |
| Wellspring Longevity Clinic | Readers who want a custom blend and will ask what theirs costs |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Vitalex Health](https://thisglp.com/reviews/vitalex-health) [Vitara RX](https://thisglp.com/reviews/vitara-rx) [VitaStir](https://thisglp.com/reviews/vitastir) [Voxy](https://thisglp.com/reviews/voxy) [Vyora Wellness](https://thisglp.com/reviews/vyora-wellness) [Vytora Health](https://thisglp.com/reviews/vytora-health)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Why is tirzepatide cheaper?

Nothing on the pages explains it. Tirzepatide is $83 and semaglutide $250, which reverses the usual order.

Should I confirm it?

Yes. A three-fold gap in the unusual direction is worth checking with the seller before ordering.

What dose do these buy?

No milligram figure is published beside either price.

Is WeightRx expensive compared with other GLP-1 telehealth sellers?

WeightRx publishes a starting figure of $83/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts WeightRx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
